- Published
- 17 June 2021
- Journal article
Women’s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic:: A qualitative evaluation
- Authors
- Source
- BJOG: An International Journal of Obstetrics and Gynaecology
Full text
Abstract
Objective
To explore the experiences of women in Scotland who accessed medical abortion at home up to 12 weeks gestation, delivered via a telemedicine abortion service implemented in response to the coronavirus (COVID-19) pandemic, to identify areas for improvement and inform service provision.
Design
Qualitative interview study.
Setting
Abortion service in one National Health Service health board in Scotland.
Population or Sample
20 women that accessed telemedicine abortion services and self-administered mifepristone and misoprostol at home up to 12 weeks gestation.
Methods
Thematic analysis of semi-structured qualitative interviews, informed by the Framework analytic approach.
Main Outcome Measures
Women’s experiences of accessing telemedicine for medical abortion at home, specifically: acceptability of the telephone consultation and remote support; views on no pre-abortion ultrasound scan; and self-administration of abortion medications at home.
Results
Novel study findings were threefold: (1) participants valued the option of accessing abortion care via telemedicine, and emphasised the benefits of providing a choice of telephone and in-person consultation to suit those with different life circumstances; (2) the quality of abortion care was enhanced by the telemedicine service in relation to access, comfort and flexibility, and ongoing telephone support; (3) participants described being comfortable with, and in some cases a preference for, not having an ultrasound scan.
Conclusions
This research demonstrates support for the continuation of telemedicine abortion services beyond the temporary arrangements in place during COVID-19, and lends weight to the argument that offering the option of telemedicine abortion care can enable women to access this essential health service.
Rights
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0/
Cite as
Boydell, N., Reynolds-Wright, J., Cameron, S. & Harden, J. 2021, 'Women’s experiences of a telemedicine abortion service (up to 12 weeks) implemented during the coronavirus (COVID-19) pandemic:: A qualitative evaluation', BJOG: An International Journal of Obstetrics and Gynaecology, 128(11), pp. 1752-1761. https://doi.org/10.1111/1471-0528.16813